Skip to main content
KOLON LIFE SCIENCE Inc. logo

KOLON LIFE SCIENCE Inc. — Investor Relations & Filings

Ticker · 102940 ISIN · KR7102940004 KO Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2024-12-24 Regulatory Filings
Country KR South Korea
Listing KO 102940

About KOLON LIFE SCIENCE Inc.

https://www.kolonls.co.kr/

KOLON LIFE SCIENCE Inc. is a company operating through two primary business divisions: Bio and Chemical. The Bio division is a clinical-stage biotechnology unit focused on developing novel cell and gene therapies, with a pipeline that includes treatments for neuropathic pain and oncolytic virus therapies for cancer. The Chemical division develops, manufactures, and sells Active Pharmaceutical Ingredients (APIs), specialty chemicals, antimicrobials, and water treatment solutions. The company leverages its expertise in both biotechnology and chemical manufacturing to provide advanced healthcare and environmental products.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약해지
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Kolon Life Science regarding the termination of a single sales and supply contract. It details the contract termination, the reason (dissolution of the counterparty), and the financial impact. This type of disclosure regarding material business contracts is classified as a general regulatory filing (RNS) as it does not fit into specific categories like M&A, dividends, or share issues.
2024-12-24 Korean
재해발생(자율공시)
Regulatory Filings Classification · 1% confidence The document is a regulatory disclosure regarding a fire incident at a company facility (Kolon Life Science). It follows the standard format for a material event disclosure (voluntary disclosure) in the Korean market. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and serves as a general regulatory announcement of a significant corporate event, it is classified as a Regulatory Filing (RNS).
2024-12-17 Korean
전환사채(해외전환사채포함)발행후만기전사채취득 (제2회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from Kolon Life Science regarding the acquisition of convertible bonds before maturity (call option exercise). It details the bond series, acquisition amount, reason for acquisition, and method of settlement. This falls under capital structure changes and financing updates, specifically related to debt instruments.
2024-12-06 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement from Kolon Life Science regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming 25th Annual General Meeting. It does not contain the full meeting materials or proxy statements, but rather serves as a formal regulatory notice of the record date. Given the nature of the announcement as a regulatory disclosure, it fits best under the RNS category.
2024-12-05 Korean
[기재정정]특수관계인으로부터받은담보
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from Kolon Life Science regarding a correction to a previous disclosure about collateral received from a related party (Kolon Biotech). It details the terms of the collateral, the board approval date, and the nature of the transaction (loan extension). Since this is a specific regulatory disclosure regarding corporate transactions and financing arrangements that does not fit into categories like earnings releases, annual reports, or shareholder meetings, it is classified as a general Regulatory Filing (RNS).
2024-12-05 Korean
투자판단관련주요경영사항 (형사재판 1심 판결 결과)
Legal Proceedings Report Classification · 1% confidence The document is a regulatory filing from Kolon Life Science regarding the outcome of a first-instance criminal trial. It details legal proceedings, specifically a court verdict (acquittal) for the former CEO and the company. Since this document reports on significant legal developments and litigation outcomes, it falls under the 'Legal Proceedings Report' category.
2024-12-03 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.